HEPTARES Trademark

Trademark Overview


On Thursday, March 26, 2015, a trademark application was filed for HEPTARES with the United States Patent and Trademark Office. The USPTO has given the HEPTARES trademark a serial number of 86577541. The federal status of this trademark filing is PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED as of Tuesday, January 2, 2024. This trademark is owned by Heptares Therapeutics Limited. The HEPTARES trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

[ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]

[ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]

Pharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes

Biotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific test...
heptares

General Information


Serial Number86577541
Word MarkHEPTARES
Filing DateThursday, March 26, 2015
Status705 - PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, January 2, 2024
Registration Number5239010
Registration DateTuesday, July 11, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements


Goods and Services[ Biological products for medical purposes, namely, g-protein-coupled receptors, transmembrane proteins and parts thereof for use in chemical and biological drug discovery, lead identification, diagnostics and therapeutic purposes; biological and chemical products for medical use, namely, proteins, G-protein-coupled receptors, transmembrane proteins, G-Proteins, antibodies and peptides and parts thereof, for therapeutic purposes; chemicals, proteins and parts thereof for use in medical diagnostics; none being dietetic substances adapted for medical use or food products ]
Translation of Words in MarkThe wording "HEPTARES" has no meaning in a foreign language.
Goods and Services[ Chemicals and proteins used in research, namely, for chemistry and biological drug discovery, lead identification and diagnostics; proteins including G-protein-coupled receptors, trans-membrane proteins and parts thereof, for use in pharmaceutical research, namely, drug discovery purposes ]
Goods and ServicesPharmaceutical advice; pharmaceutical consultancy for medical purposes; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; research, creation, development and provision of chemical and biological drug targets for medical screening purposes
Goods and ServicesBiotechnology testing, namely, genetic testing for scientific research purposes; Biotechnology research; Biotechnology development, namely, development in the field of drug discovery and biopharmaceuticals; biotechnology advice; Biotechnology consultancy; Biotechnology information, namely, providing information on the subject of scientific research in the field of biotechnology; Pharmaceutical testing; pharmaceutical research; pharmaceutical development; pharmaceutical consultancy for non-medical purposes; Providing medical and scientific research information in the fields of pharmaceuticals; scientific testing and research in the pharmaceutical and biopharmaceutical fields, namely, chemical and biological drug discovery services; providing scientific information, advice, and consultancy in the field of technologies related to proteins, including transmembrane proteins and G-proteins, and G protein coupled receptors, and parts thereof; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; Research and development in the pharmaceutical and biopharmaceutical fields, namely, technologies related to proteins and G protein coupled receptors; biology and chemistry services, namely, research and consulting in the field of chemistry and biology; pharmaceutical research services, namely, chemical and biological drug discovery services; research and development services for pharmaceutical lead identification; synthetic chemistry consultation services and research; research and development services in the creation of libraries or collections of biologicals, chemicals and compounds; research, creation, development and provision of chemical and biological drug targets for non-medical screening purposes; research, analysis and identification of compounds through automated screening processes research and development services relating to pharmaceutical research services, namely, chemical and biological drug discovery services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, January 2, 2024
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status CodeB - Sec. 8 - Class(es) in a Multiple Class registration
Class Status DateTuesday, January 2, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, April 4, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2016
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNXERA PHARMA CO., LTD
Party Type32 - New Owner After Registration
Legal Entity Type99 - Other
AddressTOKYO 107-0052
JP

Party NameSOSEI GROUP CORPORATION
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTOKYO 102-0083
JP

Party NameHeptares Therapeutics Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCambridge CB216DG
GB

Party NameHeptares Therapeutics Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressHertfordshire AL73AX
GB

Party NameHeptares Therapeutics Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressHertfordshire AL73AX
GB

Trademark Events


Event DateEvent Description
Monday, June 1, 2015ASSIGNED TO LIE
Monday, March 30, 2015NEW APPLICATION ENTERED
Saturday, April 4, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, May 27, 2015TEAS VOLUNTARY AMENDMENT RECEIVED
Friday, June 5, 2015PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, June 29, 2015ASSIGNED TO EXAMINER
Sunday, July 12, 2015NON-FINAL ACTION WRITTEN
Sunday, July 12, 2015NON-FINAL ACTION E-MAILED
Sunday, July 12, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 8, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 15, 2016ASSIGNED TO LIE
Wednesday, January 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, January 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 20, 2016REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Wednesday, January 20, 2016NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Tuesday, February 16, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 8, 2016FINAL REFUSAL WRITTEN
Tuesday, March 8, 2016FINAL REFUSAL E-MAILED
Tuesday, March 8, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, June 15, 2016TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, June 15, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 15, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 7, 2016SUBSEQUENT FINAL REFUSAL WRITTEN
Thursday, July 7, 2016SUBSEQUENT FINAL EMAILED
Thursday, July 7, 2016NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Friday, August 5, 2016NON-FINAL ACTION WRITTEN
Friday, August 5, 2016NON-FINAL ACTION E-MAILED
Friday, August 5, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, February 1, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 3, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, March 17, 2017LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, October 30, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 30, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 6, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, July 11, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, July 10, 2023TEAS SECTION 8 & 15 RECEIVED
Tuesday, January 2, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 2, 2024REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, January 2, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, July 4, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP